SION

2.8254.88%
EH

Elena H. Ridloff

CFO & Chief Business Officer

Ms. Elena H. Ridloff, CFA, is Independent Director of Immunic, Inc. from August 6, 2026. She is Independent Director of Kymera Therapeutics, Inc. from March 12, 2021. Ms. Ridloff joined the Kymera Therapeutics, Inc. on March 12, 2021. Ms. Ridloff was CFO & Head of Corporate Development of Sionna Therapeutics, Inc. from September 2021 to 2025. She is Chief Financial Officer of Sionna Therapeutics, Inc from 2025 and serves as its Chief Business Officer since September 16, 2026. Ms. Ridloff has B.A. in Sociology, Social Sciences, History from University of Pennsylvania. She also serves as Advisor at Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). Ms. Ridloff served as Executive Vice President and Chief Financial Officer at Acadia Pharmaceuticals Inc. since April 2018 until September 10, 2021 and served as its Principal Accounting Officer since November 15, 2019 until August 5, 2020. She joined ACADIA in April 2018 as Senior Vice President, Investor Relations, where she led investor and financial communications activities and since October 2018 has served as Chief Financial Officer. She served as an Independent Director at Kronos Bio, Inc. since September 2020 until June 2025. Ms. Ridloff had been Senior Vice President of Investor Relations at ACADIA Pharmaceuticals Inc. and its Interim Chief Financial Officer from October 31, 2018 to September 2021. Ms. Ridloff served as Vice President of Investor Relations at Alexion Pharmaceuticals, Inc. since January 2016 until March 2018. Ms. Ridloff served as an Executive Director of Investor Relations at Alexion Pharmaceuticals, Inc. since April 2014 until January 2016. Ms. Ridloff served as a Research Analyst for Paramount BioCapital Asset Management, Inc. since July 2001. Paramount BioCapital Asset Management, Inc. is an affiliate of Paramount BioCapital, Inc. She served as the Chief Executive Officer and Managing Member of BIOVISIO from January 2012 to April 2014. Ms. Ridloff also served as a Managing Director at Maverick Capital, a hedge fund from July 2005 to January 2012. Ms. Ridloff also spent over a decade as an institutional investor. Ms. Ridloff serves as a Director of Lantibio, Inc. Ms. Ridloff earned her B.A. in History and Sociology of Science from the University of Pennsylvania and is a Chartered Financial Analyst.

Positions